Our long-lasting collaboration with DestiNA Genomica and Optoi Microelectronics, within the framework of the miRNA-DisEASY project, has resulted in an exciting paper published in Chemical Communications.

In this paper we describe a new method, using DestiNA’s dynamic labelling chemistry of nucleic acids and based on time-gated imaging, to detect abnormal levels in microRNA-122 in drug-induced liver damaged patients.

This work opens up new lines in the continuous development of ultra-sensitive methods for biomarkers analyses in liquid biopsies.

 

Interacciones con los lectores

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *


El periodo de verificación de reCAPTCHA ha caducado. Por favor, recarga la página.